Investigation of oxidative stress parameters in treated phenylketonuric patients

Metabolic Brain Disease

Volumn 21, Issue 4, 2006, Pages 287-296

  Sitta, A ^a,b   Barschak, A G ^a,b   Deon, M ^a,b   Terroso, T ^a   Pires, R ^a   Giugliani, R ^a   Dutra Filho, C S ^b   Wajner, M ^a,b   Vargas, C R ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Dietary treatment; Free radical; Oxidative stress; Phenylketonuria

Indexed keywords

ANTIOXIDANT; BENZOPHENONE; CATALASE; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CONTROL GROUP; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; HUMAN; OXIDATIVE STRESS; PARAMETER; PATHOLOGY; PHENYLKETONURIA; REDUCTION KINETICS;

CATALASE; CHILD; ERYTHROCYTES; FREE RADICALS; GLUTATHIONE PEROXIDASE; HUMANS; LIPID PEROXIDATION; OXIDATIVE STRESS; PHENYLALANINE; PHENYLKETONURIAS; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 33845864445     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-006-9035-0     Document Type: Article

References (37)

1. Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121-126
2. Artuch R, Colome C, Sierra C, Brandi N, Lambruschini N, Campistol J, Ugarte D, Vilaseca MA (2004) A longitudinal study of antioxidant status in phenylketonuric patients. Clin Biochem 37:198-203
3. Bauman ML, Kemper TL (1982) Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria. Acta Neuropathol 58:55-63
4. Burgard P (2000) Development of intelligence in early treated phenylketonuria. Eur J Pediatr 159:74-79
5. Colome C, Sierra C, Vilaseca MA (2000) Congenital errors of metabolism: cause of oxidative stress? Med Clin 115:111-117
6. Darling G, Mathias P, O'Regan M, Naughten E (1992) Serum selenium levels in individuals on PKU diets. J Inherit Metab Dis 15:769-773
7. Ercal N, Aykin-Burns N, Gurer-Orhan H, Mcdonald JD (2002) Oxidative stress in a phenylketonuria animal model. Free Rad Biol Med 32:906-911
8. Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Meth Enzymol 186:407-421
9. Hagen MEK, Pederzolli CD, Sgaravatti AM, Bridi R, Wajner M, Wanmacher CMD, Wyse ATS, Dutra-Filho CS (2002) Experimental hyperphenylalaninemia provokes oxidative stress in rat brain. Biochim Biophys Acta 1586:344-352
10. Halliwell B, Gutteridge JMC (1985) Oxygen radicals and nervous system. Trends Neurosci 8:22-26
11. Halliwell B (1996) Free radicals, proteins and DNA: oxidative damage versus redox regulation. Biochem Soc Trans 24:1023-1027
12. Halliwel B, Gutteridge JMC (2001) Oxidative stress: adaptation, damage, repair and death. In: Halliwell B, Gutteridge JMC (eds) Free radicals in biology and medicine. Oxford University Press, Oxford, pp 246-350
13. Halliwell B, Whiteman M (2004) Measuring reactive species and oxidative damage in vivo and in cell culture: How should you do it and what do the results mean? Br J Pharmacol 142:231-255
14. Hanley WB, Lee AW, Hanley AJG, Lehotay DC, Austin VJ, Schoonheyt WE, Platt BA, Clarke JTR (2000) Hypotyrosinemia in phenylketonuria. Mol Gen Metab 69:286-394
15. Hendriksz CJ, Walter JH (2004) Update on phenylketonuria. Curr Paediatr 14:400-406
16. Lissi E, Pascual C, Del Castillo MD (1992) Luminol luminescence induced by 2,2'-azo-bis-(amidinopropane) thermolysis. Free Rac Res Commun 17:299-311
17. Lissi E, Salim-Hanna M, Pascual C, Del Castillo MD (1995). Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Rad Biol Med 18:153-158
18. Lombeck I, Jochum F, Terwolbeck K (1996) Selenium status in infants and children with phenylketonuria and in maternal phenylketonuria. Eur J Pediatr 155:140-144
19. Longhi R, Rottoli A, Vittorelli A, Zecchini G, Bonabitacola T, Bertassi F, Riva E, Giovannini M (1987) Trace elements nutriture in hyperphenylalaninemic patients: Long-term follow up study. Eur J Pediatr 146:32-37
20. Lowry OH, Rosebrough NJ, Lewis-Farr A, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
21. Martinez-Cruz F, Pozo D, Osuna C, Espinar A, Marchante C, Guerrero JM (2002) Oxidative stress induced by phenylketonuria in the rat: prevent by melatonin, vitamin E and vitamin C. J Neurosci Res 69:550-558
22. McCaman MW, Robins E (1962) Fluorimetric method for the determination of phenylalanine in serum. J Lab Clin Med 59:885-890
23. Paglia DE, Valentine WN (1967) Glutathione peroxidase. J Lab Clin Med 70:158
24. Przyrembel H, Bremer HJ (2000) Nutrition, physical growth, and bone density in treated phenylketonuria. Eur J Pediatr 159:129-135
25. Reznick AZ, Packer L (1993) Free radicals and antioxidants in muscular neurological diseases and disorders. In: Poli G, Albano E, Dianzani MU (eds) Free radicals: From basic science to medicine. Birkhauser, Basel, pp 425-437
26. Rottoli A, Lista G, Zecchini G, Butte C, Longhi R (1985) Plasma selenium levels in treated phenylketonuric patients. J Inherit Metab Dis 8:127-128
27. Schulpis KH, Tsakiris S, Karikas GA, Moukas M, Behrakis P (2003) Effect of diet on plasma total antioxidant status in phenylketonuric patients. Eur J Clin Nutr 57:282-287
28. Schulpis KH, Tsakiris S, Traeger-Synodinos J, Papassotiriou I (2005) Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria. Clin Biochem 38:239-242
29. Schulz JB, Lindenau J, Seyfried J, Dichgans J (2000) Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267:4904-4911
30. Scriver CR, Kaufmann S (2001) The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease, 8th edn. McGraw-Hill, New York, pp 1667-1724
31. Shefer S, Tint GS, Jean-Guillaume D, Daikhin E, Kendler A, Nguyen LB, Yudkoff M, Charissa A, Dyer CA (2000) Is there a relationship between 3-hydroxy-3-methylglutaryl Coenzyme A reductase activity and forebrain pathology in the PKU mouse? J Neurosci Res 61:549-563
32. Sierra C, Vilaseca MA, Moyano D, Brandi N, Campistol J, Lambruschini N, Cambra FJ, Deulofeu R, Mira A (1998) Antioxidant status in hyperphenylalaninemia. Clin Chim Acta 276:1-9
33. Sirtori LR, Dutra-Filho CS, Fitarelli D, Sitta A, Haeser A, Barschak AG, Wajner M, Coelho DM, Llesuy S, Bello-Klein A, Giugliani R, Deon M, Vargas CR (2005) Oxidative stress in patients with phenylketonuria. Biochim Biophys Acta 1740:68-73
34. van Backel MM, Printzen G, Wermuth B, Wiesmann UN (2000) Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients. Am J Clin Nutr 72:976-981
35. Wajner M, Latini A, Wyse AT, Dutra-Filho CS (2004) The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis 27:427-448
36. Weglage J, Pietsch M, Funders B, Koch HG, Ullrich K (1995) Neurological findings in early treated phenylketonuria. Acta Paediatr 84:411-415
37. Wyse ATS, Sarkis JJ, Cunha-Filho JS, Teixeira MV, Schetinger MR, Wajner M, Milton C, Wannmacher C (1994) Effect of phenylalanine and its metabolites on ATP diphosphohydrolase activity in synaptosomes from rat cerebral cortex. Neurochem Res 19:1175-1180